Aspira Women's Health (AWH) Competitors $0.75 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends AWH vs. VYNE, VRCA, OCX, ATNM, IMMX, VTVT, GANX, DBVT, AFMD, and ACHLShould you be buying Aspira Women's Health stock or one of its competitors? The main competitors of Aspira Women's Health include VYNE Therapeutics (VYNE), Verrica Pharmaceuticals (VRCA), OncoCyte (OCX), Actinium Pharmaceuticals (ATNM), Immix Biopharma (IMMX), vTv Therapeutics (VTVT), Gain Therapeutics (GANX), DBV Technologies (DBVT), Affimed (AFMD), and Achilles Therapeutics (ACHL). These companies are all part of the "pharmaceutical products" industry. Aspira Women's Health vs. VYNE Therapeutics Verrica Pharmaceuticals OncoCyte Actinium Pharmaceuticals Immix Biopharma vTv Therapeutics Gain Therapeutics DBV Technologies Affimed Achilles Therapeutics Aspira Women's Health (NASDAQ:AWH) and VYNE Therapeutics (NASDAQ:VYNE) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, media sentiment, risk, valuation, earnings and dividends. Does the MarketBeat Community prefer AWH or VYNE? VYNE Therapeutics received 16 more outperform votes than Aspira Women's Health when rated by MarketBeat users. Likewise, 63.83% of users gave VYNE Therapeutics an outperform vote while only 20.00% of users gave Aspira Women's Health an outperform vote. CompanyUnderperformOutperformAspira Women's HealthOutperform Votes1420.00% Underperform Votes5680.00% VYNE TherapeuticsOutperform Votes3063.83% Underperform Votes1736.17% Do analysts prefer AWH or VYNE? Aspira Women's Health currently has a consensus price target of $4.40, indicating a potential upside of 486.74%. VYNE Therapeutics has a consensus price target of $6.88, indicating a potential upside of 126.90%. Given Aspira Women's Health's higher probable upside, research analysts clearly believe Aspira Women's Health is more favorable than VYNE Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspira Women's Health 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50VYNE Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, AWH or VYNE? Aspira Women's Health has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, VYNE Therapeutics has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Which has better earnings and valuation, AWH or VYNE? Aspira Women's Health has higher revenue and earnings than VYNE Therapeutics. VYNE Therapeutics is trading at a lower price-to-earnings ratio than Aspira Women's Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspira Women's Health$9.15M1.32-$16.69M-$1.20-0.62VYNE Therapeutics$420K106.41-$28.45M-$0.86-3.52 Is AWH or VYNE more profitable? Aspira Women's Health has a net margin of -165.07% compared to VYNE Therapeutics' net margin of -6,896.55%. Aspira Women's Health's return on equity of 0.00% beat VYNE Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aspira Women's Health-165.07% N/A -255.28% VYNE Therapeutics -6,896.55%-43.73%-38.55% Does the media prefer AWH or VYNE? In the previous week, VYNE Therapeutics had 3 more articles in the media than Aspira Women's Health. MarketBeat recorded 5 mentions for VYNE Therapeutics and 2 mentions for Aspira Women's Health. VYNE Therapeutics' average media sentiment score of 0.20 beat Aspira Women's Health's score of 0.15 indicating that VYNE Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aspira Women's Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral VYNE Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of AWH or VYNE? 12.2% of Aspira Women's Health shares are owned by institutional investors. Comparatively, 83.8% of VYNE Therapeutics shares are owned by institutional investors. 4.3% of Aspira Women's Health shares are owned by company insiders. Comparatively, 4.8% of VYNE Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryVYNE Therapeutics beats Aspira Women's Health on 11 of the 18 factors compared between the two stocks. Ad Golden CrestBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide Get Aspira Women's Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AWH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AWH vs. The Competition Export to ExcelMetricAspira Women's HealthDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.04M$2.28B$5.38B$8.84BDividend YieldN/A0.75%5.13%4.09%P/E Ratio-0.626.13105.0417.81Price / Sales1.3243.531,235.79158.52Price / CashN/A14.8240.3536.29Price / Book-3.263.137.086.50Net Income-$16.69M$29.98M$119.58M$226.22M7 Day Performance0.04%4.76%2.25%4.03%1 Month Performance-23.48%-9.17%-2.34%4.92%1 Year Performance-76.42%-13.97%33.95%29.30% Aspira Women's Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AWHAspira Women's Health1.6508 of 5 stars$0.75flat$4.40+486.7%-76.4%$12.04M$9.15M-0.62110Analyst ForecastGap DownVYNEVYNE Therapeutics2.547 of 5 stars$3.12+7.6%$6.88+120.4%-22.3%$46.02M$420,000.00-3.6330VRCAVerrica Pharmaceuticals4.4945 of 5 stars$1.00+1.0%$9.60+860.1%-72.8%$45.60M$5.12M-0.5540News CoverageOCXOncoCyte1.2188 of 5 stars$2.69+0.7%$4.42+64.2%-33.1%$45.27M$1.50M0.00120Analyst ForecastATNMActinium Pharmaceuticals1.2874 of 5 stars$1.45-1.4%$7.40+410.3%N/A$45.24M$80,000.00-1.0649Analyst ForecastGap DownIMMXImmix Biopharma2.8927 of 5 stars$1.64-2.4%$7.00+326.8%-59.3%$45.12MN/A-1.989VTVTvTv Therapeutics0.0924 of 5 stars$14.81-0.1%N/A+34.5%$44.58M$1M-3.339GANXGain Therapeutics2.7026 of 5 stars$1.68+3.7%$7.33+336.5%-18.5%$44.55M$50,000.00-1.4820Analyst RevisionDBVTDBV Technologies2.7209 of 5 stars$0.46-5.8%$6.00+1,204.6%-70.5%$44.38M$15.73M-0.53106Analyst ForecastAFMDAffimed3.3781 of 5 stars$2.75+4.2%$16.00+481.8%-47.5%$44.28M$877,000.000.0076Analyst ForecastAnalyst RevisionACHLAchilles Therapeutics2.7854 of 5 stars$1.06-0.9%$4.00+277.4%+34.1%$43.57MN/A-0.65250 Related Companies and Tools Related Companies VYNE Alternatives VRCA Alternatives OCX Alternatives ATNM Alternatives IMMX Alternatives VTVT Alternatives GANX Alternatives DBVT Alternatives AFMD Alternatives ACHL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AWH) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspira Women's Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspira Women's Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AWH Stock Alerts